The Consensus EPS Estimates For Chengxin Lithium Group Co., Ltd. (SZSE:002240) Just Fell Dramatically
The Consensus EPS Estimates For Chengxin Lithium Group Co., Ltd. (SZSE:002240) Just Fell Dramatically
One thing we could say about the analysts on Chengxin Lithium Group Co., Ltd. (SZSE:002240) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. Revenue and earnings per share (EPS) forecasts were both revised downwards, with analysts seeing grey clouds on the horizon.
关于盛新锂能的分析师,我们可以说一件事 - 他们并不乐观,刚刚对该组织的近期(法定)预测进行了重大的负面修订。营业收入和每股收益(EPS)预测均遭到下调,分析师们看到了未来的灰暗前景。
Following the latest downgrade, the current consensus, from the four analysts covering Chengxin Lithium Group, is for revenues of CN¥9.6b in 2023, which would reflect a definite 18% reduction in Chengxin Lithium Group's sales over the past 12 months. Statutory earnings per share are supposed to dive 67% to CN¥1.12 in the same period. Previously, the analysts had been modelling revenues of CN¥11b and earnings per share (EPS) of CN¥1.61 in 2023. Indeed, we can see that the analysts are a lot more bearish about Chengxin Lithium Group's prospects, administering a measurable cut to revenue estimates and slashing their EPS estimates to boot.
根据最新的下调,覆盖盛新锂能的四位分析师的当前共识是,预计2023年营业收入为96亿人民币,这将反映出盛新锂能过去12个月销售额明显下降了18%。法定每股收益预计在同一时期将下跌67%,降至1.12人民币。此前,分析师们曾对2023年的营业收入预测为110亿人民币,每股收益(EPS)为1.61人民币。实际上我们可以看出,分析师们对盛新锂能的前景更为看淡,对营收预估进行了实质性的下调,并裁减了其每股收益预估。
View our latest analysis for Chengxin Lithium Group
查看我们对盛新锂能的最新分析
The consensus price target fell 19% to CN¥35.01, with the weaker earnings outlook clearly leading analyst valuation estimates.
共识价位目标下调19%,至35.01人民币,较弱的盈利前景明显影响了分析师的估值预测。
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. These estimates imply that sales are expected to slow, with a forecast annualised revenue decline of 33% by the end of 2023. This indicates a significant reduction from annual growth of 42% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 19% per year. It's pretty clear that Chengxin Lithium Group's revenues are expected to perform substantially worse than the wider industry.
现在来看更大的画面,我们理解这些预测的一种方式就是看它们与过去表现和行业增长预估的比较。这些预估表明,销售预计将放缓,到2023年底,年化营业收入将下降33%。这表明与过去五年的42%年增长相比,有显著降低。将此与我们的数据进行比较,我们的数据显示,同行业其他公司预计年均营收增长19%。很明显,预计盛新锂能的营业收入将远不及更广泛的行业表现。
The Bottom Line
最重要的事情是分析师增加了它对下一年每股亏损的估计。令人欣慰的是,营收预测未发生重大变化,业务仍有望比整个行业增长更快。共识价格目标稳定在28.50美元,最新估计不足以对价格目标产生影响。
The most important thing to take away is that analysts cut their earnings per share estimates, expecting a clear decline in business conditions. Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that Chengxin Lithium Group's revenues are expected to grow slower than the wider market. After such a stark change in sentiment from analysts, we'd understand if readers now felt a bit wary of Chengxin Lithium Group.
最重要的一点是,分析师下调了他们对每股收益的预期,预计业务状况将出现明显下滑。不幸的是,分析师还下调了他们的营业收入预期,而行业板块数据显示,预计盛新锂能的营业收入增长速度将低于整个市场。在分析师情绪发生如此明显变化之后,我们能理解读者现在对盛新锂能感到有些警惕。
That said, the analysts might have good reason to be negative on Chengxin Lithium Group, given concerns around earnings quality. Learn more, and discover the 3 other flags we've identified, for free on our platform here.
也就是说,分析师可能有足够的理由对盛新锂能持负面态度,鉴于对营收质量存在担忧。在我们的平台上免费了解更多信息,并发现我们发现的其他3个风险标志。
Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.
当然,看到公司管理层投资大笔资金购买股票的情况与知道分析师是否下调他们的预测一样有用。因此,您可能还想搜索这份免费的股票清单,其中列出了内部人士正在购买的股票。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?关于内容有所顾虑?直接和我们联系。或电邮 editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。